EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, 23andMe Holding Co's enterprise value is $24.8 Mil.
23andMe Holding Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $248.0 Mil. Therefore, 23andMe Holding Co's EV-to-Revenue for today is 0.10.
The historical rank and industry rank for 23andMe Holding Co's EV-to-Revenue or its related term are showing as below:
ME'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.1 Med: 2.81 Max: 20.2
Current: 0.1
During the past 4 years, the highest EV-to-Revenue of 23andMe Holding Co was 20.20. The lowest was 0.10. And the median was 2.81.
ME's EV-to-Revenue is ranked better than 93.83% of 227
companies
in the Medical Diagnostics & Research industry
Industry Median: 3.19
vs ME: 0.10
As of today (2024-04-18), 23andMe Holding Co's stock price is $0.3575.
23andMe Holding Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.53. Therefore, 23andMe Holding Co's PS Ratio for today is 0.67.
23andMe Holding Co EV-to-Revenue Historical Data
The historical data trend for 23andMe Holding Co's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
23andMe Holding Co Annual Data
Trend
Mar20
Mar21
Mar22
Mar23
EV-to-Revenue
-
-
4.61
2.50
23andMe Holding Co Quarterly Data
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
EV-to-Revenue
2.06
2.50
2.01
1.08
1.12
Competitive Comparison
For the Diagnostics & Research subindustry, 23andMe Holding Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
23andMe Holding Co EV-to-Revenue Distribution
For the Medical Diagnostics & Research industry and Healthcare sector, 23andMe Holding Co's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where 23andMe Holding Co's EV-to-Revenue falls into.
23andMe Holding Co's current Enterprise Value is $24.8 Mil.
23andMe Holding Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $248.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
23andMe Holding Co (NAS:ME) EV-to-Revenue Explanation
23andMe Holding Co's share price for today is $0.3575.
23andMe Holding Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.53.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
23andMe Holding Co EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of 23andMe Holding Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
23andMe Holding Co (23andMe Holding Co) Business Description
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment include Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ME has been successfully added to your 